Sun Pharmaceutical industries share price has declined 4-5% in 2 trading sessions following OAI status determined by the ...
Sun Pharmaceutical Industries shares dropped 3.4 percent as the US FDA labelled its Dadra facility ... taking any investment decisions. Advisory Alert: It has come to our attention that certain ...
Sun Pharma said that the US FDA conducted an inspection at the company's Dadra facility from December 4, 2023 to December 15, 2023. The US FDA has subsequently determined the inspection ...
[Related: Taro announces merger agreement with Sun Pharma] At the meetings, Taro shareholders will be asked to consider and vote on the approval, pursuant to Section 320 of the Companies Law ...
In two import alerts posted in late March and early April, the FDA said all of Jiangsu Shenli's piston syringes are subject to detention without physical examination. The agency first raised ...
The Food and Drug Administration published an expanded import alert Wednesday to stop all plastic syringes made by a Chinese manufacturer from entering the U.S. On March 28, the FDA issued an ...
Sun Pharmaceutical Industries witnessed a 3.4% decline in its shares as the US FDA categorized its Dadra facility as 'official action indicated' (OAI), suggesting recommended regulatory or ...
Fluoxetine is used for the treatment of major depressive disorder, obsessive-compulsive disorder, bulimia nervosa and panic disorder, with or without agoraphobia. Strides’ wholly owned ...
A stock is considered to be oversold if the RSI reading falls below 30. In trading on Friday, shares of Royalty Pharma plc (Symbol: RPRX) entered into oversold territory, hitting an RSI reading of ...
The Sun Pharma's ordeal with the US drug regulator continues as its Halol Manufacturing facility in Gujarat is already under USFDA scanner facing import alert. Its Mohali unit also swaits USFDA ...